STEMFlo
STEMFlo, licence 80041584: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- STEMFlo Capsules
- Licence holder
- STEMTech Canada Inc.
- NPN or DIN-HM
- 80041584
- Status
- Inactive licence
- Licence date
- 10 April 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 28.1 mg | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 7025.0 FCC HUT | Not calculated |
| Vitis vinifera Source : Graine(s) Extraction ratio : 35:1 Dry plant equivalent : 1750 mg Potency : 40.0 mg Polyphenols | 50.0 mg | Not calculated |
| Theobroma cacao Source : Graine(s) | 25.0 mg | Not calculated |
| Ribes nigrum Source : Fruit Potency : 2.5 mg Anthocyanosides | 8.3 mg | Not calculated |
| Centella asiatica Source : Plante entière Extraction ratio : 10:1 Dry plant equivalent : 1083 mg | 108.3 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Cellulose en poudre, Silice, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
To help relieve symptoms related to non-complicated venous insufficiency (CVI); Helps support cardiovascular health; Provides a source of antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use prior to or immediately after surgery; if you are allergic to plants of the Apiaceae family.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen; prior to use if you are pregnant or nursing; have gallstones or a bile duct obstruction, stomach ulcers/lesions, or excess stomach acid, or a liver disorder; are taking anticoagulants, blood thinners, anti-inflammatories, or any prescription medications. Consumption with alcohol, other medication or health product with sedative properties is not recommended. Discontinue use and consult a health care practitioner if you experience gastrointestinal upset and/or nausea which persists.
Source
Official Health Canada record, licence 80041584
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.